Targeted delivery of aerosolized fisetin-loaded polymeric nanoparticles: A promising inhalation therapy for asthma

---

Linda Jeeva Kumari

Statement of the Problem: Asthma is a chronic inflammatory lung disease which is characterized by airway hyperresponsiveness, airway inflammation and goblet cell hyperplasia. It affects about 339 million people globally with an estimation of an ad

: J Nanomater Mol Nanotechnol

Abstract

---

Biography

---

Linda Jeeva Kumari Henry is a doctoral research scholar at the Department of Pharmaceutical Technology, Centre for Excellence in Nanobio Translational Research (CENTRE), University College of Engineering (UCE), Anna University, Tiruchirappalli, Tamil Nadu, India. Her specializations include pulmonary pharmacology, drug delivery, cell culture and molecular biology. She has worked as a junior research fellow in the Government of India sponsored National Facility for Drug Development, and has handled the responsibility of organizing cell culture facility, laboratory of pulmonary research. Her research focuses on developing targeted drug delivery system for the management of asthma. She has actively participated and presented papers in various national and international conferences. She has published eleven research articles in peer-reviewed journals with a cumulative impact factor of 32.459. Her passion is to explore the potentials offered by nanotechnology in the arena of translational medicine that could benefit the society, thereby improving the quality of human life.